Cancer pain is often incapacitating and discouraging to patients; is demoralizing to family members and care takers; and is taxing and difficult to subdue for the pain specialists. The consequences of implementing suboptimal treatment are far-reaching; therefore, effective treatment methods are in ...
In addition to emerging treatment options, the speakers addressed the importance of individualized decision-making when treating patients with multiple myeloma. Image credit: freshidea | stock.adobe.com During a presentation at the National Comprehensive Cancer Network Annual 2024 Conference in Orlando, ...
Immunotherapy: new options in breast cancer treatment [ J ]. Expert Rev Anticancer Ther , 2003, 3(3) :403 -408.Untch M,Ditsch N,Hermelink K.Immunotherapy: new options in breast cancer treatment.[J].2003,3(3).Untch M,Ditsch N,Hermelink K.Immunotherapy:new options in breast cancer ...
However, over the years, surgical treatment of liver cancer has advanced. Surgeons have developed new surgical techniques to reduce pain, blood loss and morbidity during resections. At the same time, liver transplant is also gaining ground as a solution to patients with liver cancer. As with...
PT Staff:Could you discuss some recent clinical trials and how outcomes have impacted the NSCLC treatment landscape? Whitney E. Lewis, PharmD, BCOP:It's been really exciting to be in the lung cancer clinic for the last several years. I like to tell my residents tha...
A minimally-invasive treatment using MRI and transurethral ultrasound instead of surgery or radiation is effective in treating prostate cancer, according to new research to be presented at the Society of Interventional Radiology Annual Scientific Meeting
Dec. 11, 2002 — Two presentations at the 25th Annual San Antonio Breast Cancer Symposium on Dec. 11 suggest new treatment options in advanced breast cancer refractory to conventional chemotherapy. A double-blind crossover trial showed that anastrozole (ARI) should be given as first-line adjuvant...
Mount Sinai researchers have broken new ground in the understanding of the MDM2 gene—which is often overexpressed in cancer—finding that when it acts with a specific protein, it can lead to cancer cell death. The study appears in the May 2, 2019, print
of the liver and an AFP-test every 6 months, whereas an MR1-scan should be performed once a year, as a basis for further treatment options.doi... RA Charo - 《New England Journal of Medicine》 被引量: 201发表: 2005年 The Promise and Perils of Antioxidants for Cancer Patients. The ...
Druggable oncogene-driven non-small cell lung cancer has led to innovative systemic treatment options, improving patients' outcome. This benefit is not only achieved in the metastatic setting but also in the postsurgical setting, such as in lung cancers harboring a common sensitizing EGFR mutation or...